Sale

Cardiopulmonary Bypass Equipment Market

Global Cardiopulmonary Bypass Equipment Market Size, Share, Growth, Analysis, Report: By Type: Single Roller Pump, Double Roller Pump; By End User: Hospitals, Ambulatory Surgical Centres; Market Dynamics; Regional Analysis; Patent Analysis; Grants Analysis; Clinical Trials Analysis; Funding and Investment Analysis; Supplier Landscape; 2024-2032

Global Cardiopulmonary Bypass Equipment Market Outlook

The global cardiopulmonary bypass equipment market size was valued at USD 285.52 million in 2023, driven by the increasing prevalence of cardiovascular diseases and developments in surgical techniques. The market is expected to grow at a CAGR of 4% during the forecast period of 2024-2032, with the values likely to rise from USD 296.94 million in 2024 to USD 406.39 million by 2032.

 

Cardiopulmonary Bypass Equipment: Introduction

Cardiopulmonary bypass equipment, also known as on the pump or heart-lung machine, inhibits blood flow towards the heart and lungs at the time of a surgery. It empties the heart and stops it from beating so that the surgeons can work on it efficiently. In addition, it also helps in removing carbon dioxide and oxygenating blood.

 

A cardiopulmonary bypass machine consists of cannulas, reservoir container, pump, and oxygenator. It can provide several benefits like preventing blood loss and swelling during surgery, making the heart still so that the surgeons can operate on the heart effectively and protects the cardiac muscle tissue.

 

Global Cardiopulmonary Bypass Equipment Market Analysis

Cardiopulmonary bypass (CPB) technology is widely used in bypass coronary arteries, repairing, and replacing heart valves, treating aortic pathologies and even heart transplants. With the incidence of cardiac surgeries, the cardiopulmonary bypass equipment market value has experienced a considerable growth.

 

As there is a prevalence towards minimally invasive surgeries, there has been a change in the standard CPB circuits. Conventionally it used to be a closed circuit, however, to avoid mass bleeding during re-transfusion, it has been changed to open circuits. Similarly, bubble oxygenators have now evolved to membrane oxygenators and there has been a shift from traditional rollers to centrifugal pumps. Therefore, there has been continuous research and innovation to improve the existing technologies with a vision to bring better treatment options for the patients.

 

In April 2024, LivaNova launched Essenz Heart Lung Machine (HLM), to support open-heart surgeries in adult as well as paediatric patients. It comes with a personalized perfusion approach that allows accurate sensing for data driven decision making. It has also gained FDA approval. Essenz HLM utilises contemporary technologies that provide accuracy and efficacy in the procedure. For instance, it offers better visibility with an intuitive graphic user interface. It also integrates cybersecurity provisions to safeguard a patients’ data. Such technical advancements indicate that cardiopulmonary bypass equipment market growth is definite in the future as well.

 

Global Cardiopulmonary Bypass Equipment Market Segmentation

Market Breakup by Type

  • Single Roller Pump
  • Double Roller Pump

 

Market Breakup by End User

  • Hospitals
  • Ambulatory Surgical Centers

 

Market Breakup by Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

 

Global Cardiopulmonary Bypass Equipment Market Overview

Every year, around 2 million  people undergo open heart surgeries to treat various cardiac problems. Owing to the high incidence of cardiac diseases and an aging population, the North American region has held majority of the cardiopulmonary bypass equipment market share. The presence of key healthcare players in the United States along with a strong infrastructure to support technology driven equipment has led to the considerable market size.

 

The Asia Pacific market size is expected to grow fastest owing to the rising geriatric population and chronic diseases associated with it. There has been critical emphasis on educating the masses with relevant information revolving around cardiac health. Moreover, with the easy availability of resources and the government inviting foreign capital investments, a proficient research and technology supported infrastructure will create significant value to fuel market growth in the future.

 

Global Cardiopulmonary Bypass Equipment Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

 

  • Medtronic
  • LivaNova Plc
  • MAQUET Holding
  • Abiomed
  • Brail Biomedica
  • Tianjin Medica
  • Terumo Corp
  • Senko Medical Instrument Manufacturing Co.
  • Technowood Corp
  • Sorin

 

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Type
  • End User
  • Region
Breakup by Type
  • Single Roller Pump
  • Double Roller Pump
Breakup by End User
  • Hospitals
  • Ambulatory Surgical Centres
Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Competitive Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • Medtronic
  • LivaNova Plc
  • MAQUET Holding
  • Abiomed
  • Brail Biomedica
  • Tianjin Medica
  • Terumo Corp
  • Senko Medical Instrument Manufacturing Co.
  • Technowood Corp
  • Sorin

 

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1    Preface
    1.1    Objectives of the Study
    1.2    Key Assumptions
    1.3    Report Coverage – Key Segmentation and Scope 
    1.4    Research Methodology
2    Executive Summary
3    Global Cardiopulmonary Bypass Equipment Market Overview 

    3.1    Global Cardiopulmonary Bypass Equipment Market Historical Value (2017-2023) 
    3.2    Global Cardiopulmonary Bypass Equipment Market Forecast Value (2024-2032)
4    Global Cardiopulmonary Bypass Equipment Market Landscape
    4.1    Global Cardiopulmonary Bypass Equipment: Developers Landscape
        4.1.1    Analysis by Year of Establishment
        4.1.2    Analysis by Company Size
        4.1.3    Analysis by Region
    4.2    Global Cardiopulmonary Bypass Equipment: Product Landscape
        4.2.1    Analysis by Method
        4.2.2    Analysis by Technology
        4.2.3    Analysis by Applications
5    Global Cardiopulmonary Bypass Equipment Market Dynamics
    5.1    Market Drivers and Constraints
    5.2    SWOT Analysis
    5.3    Porter’s Five Forces Model
    5.4    Key Demand Indicators 
    5.5    Key Price Indicators
    5.6    Industry Events, Initiatives, and Trends  
    5.7    Value Chain Analysis
6    Global Cardiopulmonary Bypass Equipment Market Segmentation
    6.1    Global Cardiopulmonary Bypass Equipment Market by Type
        6.1.1    Market Overview    
        6.1.2    Single Roller Pump
        6.1.3    Double Roller Pump
    6.2    Global Cardiopulmonary Bypass Equipment Market by End User 
        6.2.1    Market Overview
        6.2.2    Hospitals
        6.2.3    Ambulatory Surgical Centres
    6.3    Global Cardiopulmonary Bypass Equipment Market by Region
        6.3.1    Market Overview
        6.3.2    North America
        6.3.3    Europe 
        6.3.4    Asia Pacific
        6.3.5    Latin America
        6.3.6    Middle East and Africa
7    North America Cardiopulmonary Bypass Equipment Market
    7.1    Market Share by Country
    7.2    United States of America
    7.3    Canada
8    Europe Cardiopulmonary Bypass Equipment Market
    8.1    Market Share by Country
    8.2    United Kingdom
    8.3    Germany
    8.4    France
    8.5    Italy
    8.6    Others
9    Asia Pacific Cardiopulmonary Bypass Equipment Market
    9.1    Market Share by Country
    9.2    China
    9.3    Japan
    9.4    India
    9.5    ASEAN
    9.6    Australia
    9.7    Others
10    Latin America Cardiopulmonary Bypass Equipment Market
    10.1    Market Share by Country
    10.2    Brazil
    10.3    Argentina
    10.4    Mexico
    10.5    Others
11    Middle East and Africa Cardiopulmonary Bypass Equipment Market
    11.1    Market Share by Country
    11.2    Saudi Arabia
    11.3    United Arab Emirates
    11.4    Nigeria
    11.5    South Africa
    11.6    Others
12    Regulatory Framework
    12.1    Regulatory Overview
        12.1.1    US FDA
        12.1.2    EU EMA
        12.1.3    INDIA CDSCO
        12.1.4    JAPAN PMDA
        12.1.5    Others
13    Patent Analysis
    13.1    Analysis by Type of Patent
    13.2    Analysis by Publication year
    13.3    Analysis by Issuing Authority
    13.4    Analysis by Patent Age
    13.5    Analysis by CPC Analysis
    13.6    Analysis by Patent Valuation 
    13.7    Analysis by Key Players
14    Grants Analysis
    14.1    Analysis by year
    14.2    Analysis by Amount Awarded
    14.3    Analysis by Issuing Authority
    14.4    Analysis by Grant Application
    14.5    Analysis by Funding Institute
    14.6    Analysis by NIH Departments
    14.7    Analysis by Recipient Organization 
15    Clinical Trials Analysis
    15.1     Analysis by Trial Registration Year
    15.2    Analysis by Trial Status
    15.3    Analysis by Trial Phase
    15.4    Analysis by Therapeutic Area
    15.5    Analysis by Geography
16    Funding and Investment Analysis
    16.1    Analysis by Funding Instances
    16.2    Analysis by Type of Funding
    16.3    Analysis by Funding Amount
    16.4    Analysis by Leading Players
    16.5    Analysis by Leading Investors
    16.6    Analysis by Geography
17    Partnership and Collaborations Analysis
    17.1    Analysis by Partnership Instances
    17.2    Analysis by Type of Partnership
    17.3    Analysis by Leading Players
    17.4    Analysis by Geography
18    Supplier Landscape
    18.1    Medtronic
        18.1.1    Financial Analysis
        18.1.2    Product Portfolio
        18.1.3    Demographic Reach and Achievements
        18.1.4    Mergers and Acquisitions
        18.1.5    Certifications 
    18.2    LivaNova Plc
        18.2.1    Financial Analysis
        18.2.2    Product Portfolio
        18.2.3    Demographic Reach and Achievements
        18.2.4    Mergers and Acquisitions
        18.2.5    Certifications
    18.3    MAQUET Holding 
        18.3.1    Financial Analysis
        18.3.2    Product Portfolio
        18.3.3    Demographic Reach and Achievements
        18.3.4    Mergers and Acquisitions
        18.3.5    Certifications
    18.4    Abiomed
        18.4.1    Financial Analysis
        18.4.2    Product Portfolio
        18.4.3    Demographic Reach and Achievements
        18.4.4    Mergers and Acquisitions
        18.4.5    Certifications
    18.5    Brail Biomedica
        18.5.1    Financial Analysis
        18.5.2    Product Portfolio
        18.5.3    Demographic Reach and Achievements
        18.5.4    Mergers and Acquisitions
        18.5.5    Certifications
    18.6    Tianjin Medica
        18.6.1    Financial Analysis
        18.6.2    Product Portfolio
        18.6.3    Demographic Reach and Achievements
        18.6.4    Mergers and Acquisitions
        18.6.5    Certifications
    18.7    Terumo Corp
        18.7.1    Financial Analysis
        18.7.2    Product Portfolio
        18.7.3    Demographic Reach and Achievements
        18.7.4    Mergers and Acquisitions
        18.7.5    Certifications
    18.8    Senko Medical Instrument Manufacturing Co.
        18.8.1    Financial Analysis
        18.8.2    Product Portfolio
        18.8.3    Demographic Reach and Achievements
        18.8.4    Mergers and Acquisitions
        18.8.5    Certifications
    18.9    Technowood Corp
        18.9.1    Financial Analysis
        18.9.2    Product Portfolio
        18.9.3    Demographic Reach and Achievements
        18.9.4    Mergers and Acquisitions
        18.9.5    Certifications
    18.10    Sorin
        18.10.1    Financial Analysis
        18.10.2    Product Portfolio
        18.10.3    Demographic Reach and Achievements
        18.10.4    Mergers and Acquisitions
        18.10.5    Certifications
19    Key Opinion Leaders (KOL) Insights (Additional Insight)
20    Company Competitiveness Analysis (Additional Insight)

    20.1    Very Small Companies
    20.2    Small Companies
    20.3    Mid-Sized Companies
    20.4    Large Companies
    20.5    Very Large Companies
21    Payment Methods (Additional Insight)
    21.1    Government Funded
    21.2    Private Insurance
    21.3    Out-of-Pocket

 

*Additional insights provided are customisable as per client requirements.

Key Questions Answered in the Report

The market attained a value of about USD 285.52 million in 2023, driven by the increasing volume of cardiovascular diseases in the aging population and extensive research and innovations in healthcare industry.

The market is anticipated to grow at a CAGR of 4% during the forecast period of 2024-2032, likely to reach a market value of USD 406.39 million by 2032.

The market demand has grown with the incidence of cardiovascular diseases and increased awareness on cardiovascular health by government.

The current market scenario involves the preference of minimally invasive techniques for any surgery followed by the adoption of digital and artificial intelligence driven techniques to make the procedure accurate and avoid any post-surgical complications.

Single and double roller pumps are used in cardiopulmonary bypass equipment.

The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America is currently leading the global market.

The end users in the market include hospitals and ambulatory surgical centres.

Key players involved in the market are Medtronic, LivaNova Plc, MAQUET Holding, Abiomed, Brail Biomedica, Tianjin Medica, Terumo Corp, Senko Medical Instrument Manufacturing Co., Technowood Corp, and Sorin.

Purchase Full Report

Mini Report

$ 3499     $2999
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 5999     $5499
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
most popular

Five User License

$ 8299     $7499
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 10499     $9499
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER